Blue reliever inhalers act quickly to treat symptoms and attacks, and people need to carry them for if their asthma flares up.However, a new warning from the regulator, the UK's Medicines and ...

Researchers have identified a compound that could block certain life-threatening and hard-to-treat allergic reactions.

The CSU indication is the seventh disease driven in part by underlying type 2 inflammation in which Dupixent has received approval.

This reminder follows updates to product information and the National Institute for Health and Care Excellence (NICE) ...

However, the Medicines and Healthcare products Regulatory Agency (MHRA) has warned that asthma sufferers should not rely on ...

Physicians and patient advocates are sounding the alarm after the NIH abruptly withdrew a grant renewal application for the ...

President Trump has ordered agencies to act “urgently” to curb asthma—a goal at odds with moves to roll back air pollution ...

The FDA has approved the popular drug Dupixent (generic name, dupilumab) for adults and kids 12 and up with chronic spontaneous urticaria (CSU), a long-lasting itchy skin condition, when regular ...